Bruce D. Rapkin
Papers
2
Total Citations
609
H-Index
2
About
Bruce D. Rapkin is a leading urologic oncologist whose work has fundamentally shaped the surgical management of bladder cancer. His primary research focuses on radical cystectomy outcomes, with a particular emphasis on comparing open and robotic-assisted surgical approaches through rigorous clinical trials. Dr. Rapkin’s landmark 2014 randomized clinical trial comparing open radical cystectomy and robot-assisted laparoscopic radical cystectomy remains a cornerstone in the field, accumulating 596 citations and providing critical evidence on perioperative outcomes. His ongoing contributions include detailed analyses of health-related quality of life following these procedures, as demonstrated in his 2023 study examining validated patient-reported outcomes from the same randomized trial cohort. By integrating surgical innovation with patient-centered endpoints, Dr. Rapkin has helped establish evidence-based standards for bladder cancer surgery. His work continues to influence clinical decision-making and surgical practice, ensuring that both oncologic efficacy and quality of life are prioritized in the treatment of patients with muscle-invasive bladder cancer.
Research Focus
Key Achievements
Top Papers
- 1
- 2